Item 9 Labs Corp (INLB)

A Management Change

Joe GomesMedia Inquiries
Senior Generalist Equity Analyst
December 1, 2022
Report ID: 25427
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

Item 9 Labs Corp
Item 9 Labs Corp
Drug Manufacturers
Current Price
$0.125 -10.71%
Market Cap
Price Target
Refer to Report
52wk Range
$0.035 - $1.5
Related Research Reports

First Quarter Earnings Released
First Quarter Earnings Released (INLB)

Reports 4Q and Full Year 2022 Results
Reports 4Q and Full Year 2022 Results (INLB)

Going Into New Jersey
Going Into New Jersey (INLB)

A Management Change
A Management Change (INLB)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.